Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice

Objective. The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice. Methods. Patients treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) were retr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fabbroni, Marta, Cantarini, Luca, Caso, Francesco, Costa, Luisa, Pagano, Veronica Anna, Frediani, Bruno, Manganelli, Stefania, Galeazzi, Mauro
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119698/
https://ncbi.nlm.nih.gov/pubmed/25110401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/862969
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars